Ventum Cap Mkts upgraded shares of MariMed (OTCMKTS:MRMD – Free Report) to a strong-buy rating in a report published on Thursday morning, Zacks.com reports.
MariMed Price Performance
Shares of MariMed stock opened at $0.18 on Thursday. MariMed has a twelve month low of $0.14 and a twelve month high of $0.55. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55. The firm has a market cap of $67.92 million, a P/E ratio of -4.47 and a beta of 2.80. The firm’s 50-day simple moving average is $0.18 and its 200-day simple moving average is $0.24.
MariMed Company Profile
Featured Stories
- Five stocks we like better than MariMed
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- What is a Dividend King?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.